Background: Sleep disorders are strongly associated with childhood nocturnal enuresis (NE). In this study, we examined whether sleep disorders are present in children with NE, and whether NE is caused by sleeping disorders, or is simply comorbid. Methods: We examined 14 children with monosymptomatic NE and 15 age-matched controls. Sleep disorders were assessed for ≥5 days using contactless biomotion sensors to detect breathing and body movements during at-home sleep.
The type of sleep disorders that might be associated with NE is not entirely clear; although patients with NE have been found to have high arousal thresholds, 3 few investigations have examined sleep quality. Those that have studied sleep quality in patients with NE often use questionnaire-based research, 4, 5 and analysis of sleep-wake rhythms using in-hospital polysomnography (PSG). [6] [7] [8] Questionnaire, however, do not evaluate actual sleep, and PSG is limited to non-physiological sleep because it requires patient hospitalization. Although one report claims to have used actigraphs to evaluate physiological sleep at home, 9 that study required patients to wear a device on their arm, and so did not examine actual physiological sleep.
The aim of the present study was to determine whether children with NE have sleep disorders and, if so, to ascertain whether they cause NE or whether the two are simply comorbid conditions. To this end, we evaluated at-home sleep using newly developed contactless biomotion sensors.
Methods

Participants
We examined 14 children with persistent NE who had no positive changes with lifestyle modifications. They were patients with primary monosymptomatic NE who sought treatment at Kansai Medical University Hospital between January 2014 and May 2016 with a main complaint of NE. The following patients were excluded from the study: patients with apparent underlying diseases that could cause NE, such as urinary tract infection or diabetes; patients with secondary NE; patients with daytime incontinence; patients for whom psychological factors were thought to be involved; patients with developmental delay. No patients with allergies such as asthma, atopic dermatitis, or food allergies were eligible for this study. Patients taking medication that might affect quality of sleep, including anti-allergic drugs and anti-epileptic drugs were also excluded. Fifteen volunteers without NE also participated in the study as healthy controls. They were ≥5 years old and were age-matched to the study group. The control group consisted of family members of the authors.
Informed consent was obtained from all individual participants (from the children directly or from their parents) included in this study. This study was approved by the ethics committee of Kansai Medical University (No.H131050). All procedures involving human participants were performed in accordance with the ethics standards of the institutional and/or national research committee, and in accordance with the 1964 Declaration of Helsinki, its later amendments, or comparable ethical standards.
Contactless biomotion sensors
We defined a sleep disorder as poor-quality sleep, and evaluated sleep quality using contactless biomotion sensors (HSL-101; Omron Healthcare, Kyoto, Japan). These devices emitted signals in the 10.5 GHz radiofrequency band, thereby ensuring contactless detection of respiration (thoracic motion) and body movement. Sleep and waking states were determined every 30 s. Quality of sleep assessment via biomotion sensors has been found to have high agreement rates with that using PSG.
10,11
Measures of sleep quality
The parameters for evaluating sleep quality were based on measurements of sleep efficiency (total sleep time/[total time in bedÀtime out of bed] 9 100) and the number of shallow sleep episodes, as determined by the sleep sensor. We calculated median sleep efficiency and the number of shallow sleep episodes per night by measuring individual patients for a minimum of 5 days. Results from the NE and control groups were compared.
Effect of NE on quality of sleep
To ascertain whether sleep disorders cause NE or whether they are simply comorbid with it, we investigated sleep efficiency and the number of shallow sleep episodes per night before and after combination therapy (a bedwetting alarm, an anticholinergic drug, and 1-deamino-8-D-arginine vasopressin
[DDAVP]). The comparisons were made for five patients who achieved a complete response (zero bedwetting episodes for 1 month).
Statistical analysis
We used the Mann-Whitney U-test and Wilcoxon signed-rank sum test for the group comparisons. Significance was set at P < 0.05.
Results
Quality of sleep
The NE group consisted of 14 children with persistent NE (median age, 9.60 years; 9 boys and 6 girls) and the control group consisted of 15 age-matched volunteer children (median age, 9.60 years; 7 boys and 8 girls). Measurements of sleep quality were taken for ≥5 days (NE group: median, 10 days; control group: median, 7 days). Median sleep efficiency was significantly lower in the NE group (87.3%) than in the control group (93.4%; P < 0.001; Fig. 1a) . The median number of shallow sleep episodes per night was significantly higher in the NE group (5.11) than in the control group (1.50; P < 0.001; Fig. 1b ). The NE group had ≥85% wet nights in 1 month during the sleep sensor-recording period.
Effect of NE on quality of sleep
In the five children whose NE was completely halted in response to the bedwetting-alarm therapy (median age, 10.60 years; 4 boys and 1 girl), and for whom we evaluated sleep quality via sensors before and after treatment, we found no significant change in median sleep efficiency or in the number of shallow sleep episodes per night (efficiency: before, 86.0%; after, 86.2%, P = 0.50, Fig. 2a ; no. shallow sleep episodes per night: before, 5.50; after, 3.50, P = 0.22, Fig. 2b ). 
Discussion
Here, we have demonstrated that patients with NE have poorquality sleep, and that this is unlikely to be the cause of their NE. This is based on results garnered from the evaluation of physiological sleep in children with NE. Causes of childhood NE may include immature bladder function (urination control), nocturnal polyuria, psychological factors, genetic factors, delayed development of the central nervous system, and sleep disorders. 12 Of these, immature bladder function, nocturnal polyuria, and sleep disorders are considered to play particularly important roles. 2 Poor quality of sleep has been repeatedly reported in NE patients, 4-9 but many of these reports were questionnaire-based evaluations, 4, 5 or in-hospital sleep-wake rhythm analyses, [6] [7] [8] and thus did not evaluate actual physiological sleep. Although studies using actigraphs have evaluated physiological sleep at home, 9 these studies required patients to wear a device on their arm. As such, they also cannot be considered to have analyzed actual physiological sleep. This study differs from previous studies in that we used contactless biomotion sensors to evaluate the quality of physiological sleep.
Disordered sleep in NE patients is characterized by a high arousal threshold. 3 At-home PSG sleep evaluations in patients with NE have shown that arousal signs are seen immediately before NE occurs, although these patients are deep sleepers with high arousal thresholds. 13 One study has assessed sleep in patients with NE at home using actigraph units attached to the wrist or ankle. The authors recorded sleep and wake times, and found that NE patients either had a high number of nocturnal awakenings and took more time to fall asleep, or had fragmented sleep and high arousal thresholds. 9 Fragmentation of sleep in patients with NE has also been reported by Dhondt et al., 14 who used a video-PSG technique. Based on previous reports and the present results, we suggest that children with NE have poor sleep quality, even when sleeping in their own homes. The sleep arousal mechanism associated with the desire to urinate is unclear. Researchers have speculated that a bladder-filling stimulus is communicated to the pontine micturition center via the autonomic nervous system. Following this, the pontine reticular activating system is triggered, thus waking the individual. Patients with NE might have disruptions in the autonomic nervous system and pontine system. 2 In this study, we sought to determine whether NE in children is caused by sleep disorders. We evaluated sleep in five patients before and after NE was halted through therapy. We found that sleep disorders did not improve even after NE had stopped. Therefore, the poor quality of sleep observed in children with NE does not appear to be the cause of NE, but rather a comorbid condition.
The present study had several limitations that should be considered. First, the number of patients in this study was small. We plan to increase the number of cases to confirm the reproducibility of the research results. Second, because the patients were treated with combination therapy that included alarm, DDAVP, and anticholinergics, we could not identify which treatment was responsible for stopping the NE. Alarm therapy and DDAVP are known to affect sleep disorders. Alarm therapy has been reported to promote arousal in the central nervous system. 15 Additionally, treatment with DDAVP has been reported to halt NE in patients with nephrogenic diabetes insipidus 16 and to improve the lower-than-normal sensory-nerve responses in children with NE. 17 Third, this study evaluated sleep after NE was cured, but we did not evaluate whether or not NE could be cured via medication that improves sleep. Personal observations in one childhood case of NE were that oral treatment using a melatonin analogue improved sleep, but did not improve the NE. A previous study found that when melatonin was given to children with NE to improve sleep quality, there was no significant improvement in NE, even though the quality of sleep improved. 18 Furthermore, when DDAVP was used with or without melatonin, melatonin did not have any significant additive effect on NE. 19 Based on these findings, we believe that sleep disorders, defined as poor sleep quality, are comorbid symptoms with NE. Thus, correcting sleep disorders does not appear to be a viable treatment route for NE.
